Table 6:
Recommendation for secondary cytoreduction based on disease free interval and number of recurrence site.
Disease free
Single site
Multiple site
Carcinomatosis
interval
no carcinomatosis
6–12 Mo
offer SC
consider SC
No SC
12–30 Mo
offer SC
offer SC
consider SC
>
30 Mo
offer SC
offer SC
offer SC
DFI: disease free interval. SC: secondary cytoreduction. Chi et al. [
21
].